They are susceptible to the antibiotics amikacin, ethambutol, and sulfamethoxazole but show intermediate susceptibility to ciprofloxacin, doxycycline and tobramycin and variable susceptibility to cefmetazole, cefoxitin and clarithromycin.
They are susceptible to amikacin, ethambutol, and sulfamethoxazole but exhibit intermediate susceptibility to ciprofloxacin, doxycycline, and tobramycin, with varying levels of susceptibility to cefmetazole, cefoxitin, and clarithromycin.